Neonatal thrombosis: risk factors and principles of prophylaxis

Data analysis on the pathogenesis and risk factors of neonatal thrombosis was carried out. The main risk factor of any neonatal thrombosis is central catheter installment, but other maternal, fetal and neonatal factors should be taken into consideration. We discuss the epidemiology of neonatal thrombosis and the main features of the hemostasis system in newborns, the most significant risk factors, including genetic and acquired thrombophilia. We consider the von Willebrand factor activity and ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) level in the development of neonatal thrombotic microangiopathy. Finally, we discuss the basic principles of prevented neonatal thrombosis by using low molecular weight heparins.

1. Volodin N.N., Roitman E.V., Rumyantsev A.G., Shneyder M.M. Thromboses in the neonate: pathogenesis, diagnosis, treatment. [Trombozy u novorozhdennyh: patogenez, diagnostika, lechenie]. Voprosy prakticheskojpediatrii. 2012;7(4):34-43. (In Russ.).

2. Saracco P., Bagna R., Gentilomo C. et al.; Neonatal Working Group of the Registro Italiano Trombosi Infantili (RITI). Clinical data of neonatal systemic thrombosis. JPediatr. 2016;171:60-6.e1. https://doi.org/10.1016/j.jpeds.2015.12.035.

3. Bhatt M.D., Chan A.K. Venous thrombosis in neonates. Fac Rev. 2021;10:20. https://doi.org/10.12703/r/10-20.

4. Raffini L., Huang Y.S., Witmer C., Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001-8. https://doi.org/10.1542/ peds.2009-0768.

5. Saxonhouse M.A. Thrombosis in the neonatal intensive care unit. Clin Perinatol. 2015;42(3):651-73. https://doi.org/10.1016/j.clp.2015.04.010.

6. Saracco P., Parodi E., Fabris C. et al. Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors. Thromb Res. 2009;123(6):805-9. https://doi.org/10.1016/j.thromres.2008.12.002.

7. Strauss T., Levy-Shraga Y., Ravid B. et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost. 2010;103(2):344-50. https://doi.org/10.1160/TH09-05-0282.

8. Kenet G., Nowak-Gottl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol. 2012;25(3):333-44. https://doi.org/10.1016/j.beha.2012.07.001.

9. El-Naggar W., Yoon E.W., McMillan D. et al.; Canadian Neonatal Network Investigators. Epidemiology of thrombosis in Canadian neonatal intensive care units. JPerinatol. 2020;40(7):1083-90. https://doi.org/10.1038/s41372-020-0678-1.

10. Kenet G., Cohen O., Bajorat T., Nowak-Gottl U. Insights into neonatal thrombosis. Thromb Res. 2019;181(Suppl 1):S33-S36. https://doi.org/10.1016/S0049-3848(19)30364-0.

11. Haley K.M. Neonatal venous thromboembolism. Front Pediatr. 2017;5:136. https://doi.org/10.3389/fped.2017.00136.

12. Veldman A., Nord M.F., Michel-Behnke I. Thrombosis in the critically ill neonate: incidence, diagnosis, and management. Vask Health Risk Manag. 2008;4(6):1337-48. https://doi.org/10.2147/vhrm.s4274.

13. Martin G., Thomas M.A., Wei X.C., Le D. Diffuse intracerebral hemorrhage in an infant with a novel homozygous variant leading to severe protein C deficiency. J Pediatr Hematol Oncol. 2020 Nov 6. https://doi.org/10.1097/MPH.0000000000001993.

14. Kraus F.T. Fetal thrombotic vasculopathy: perinatal stroke, growth restriction, and other sequelae. Surg Pathol Clin. 2013;6(1):87-100. https://doi.org/10.1016/j.path.2012.10.001.

15. Young G., Albisetti M., Bonduel M. et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and metaanalysis of observational studies, Circulation. 2008;118(13):1373—82. https://doi.org/10.1161/CIRCULATIONAHA.108.789008.

16. Monagle P., Ignjatovic V., Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24(2):63-8. https://doi.org/10.1016/j.blre.2009.12.001.

17. Shabalov N.P., Ivanov D.O., Shabalova N.N. Dynamic of hemostasis in first week of life as reflection of adaptive mechanisms to extrauterine life. [Gemostaz v dinamike pervoj nedeli zhizni kak otrazhenie mekhanizmov adaptacii k vneutrobnoj zhizni novorozhdennogo]. Pediatriya. Zhurnal imeni G.N. Speranskogo. 2000;79(3):22. 2000;79(3):22. (In Russ.).

18. Koltsova E.M., Balashova E.N., Panteleev M.A., Balandina A.N. Laboratory aspects of hemostasis in neonates. [Laboratornye aspekty gemostaza novorozhdennyh]. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2018;17(4):100-13. https://doi.org/10.24287/1726-1708-2018-17-4-100-113. (In Russ.).

19. Ignjatovic V., Pelkmans L., Kelchtermans H. et al. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults. Thromb Res. 2015;136(6):1303-9. https://doi.org/10.1016/j.thromres.2015.10.034.

20. Cherkasova S.V. Hemostasis of newborns. [Gemostaz novorozhdennyh]. Praktikapediatra. 2020;(1):49-52. (In Russ.).

21. Nowak-Gottl U., Limperger V., Kenet G. et al. Developmental hemostasis: a lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cell Mol Dis. 2017;67:2-13. https://doi.org/10.1016/j.bcmd.2016.11.012.

22. Ignjatovic V. 30 years of developmental haemostasis: what have we learnt and how are we applying this knowledge. Thromb Res. 2018;172:188-9. https://doi.org/10.1016/j.thromres.2018.11.021.

23. Leonova E.Yu., Sinyakin O.Yu. Peculiarities of hemostasis system in newborns. [Osobennosti sistemy gemostaza u novorozhdennyh detej]. Ohrana materinstva i detstva. 2016;(2):76-81. (In Russ.).

24. Strauss T., Sidlik-Muskatel R., Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16(6):301-4. https://doi.org/10.1016/j.siny.2011.07.001.

25. Wiedmeier S.E., Henry E., Sola-Visner M.C., Christensen R.D. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol. 2009;29(2):130-6. https://doi.org/10.1038/jp.2008.14.

26. Strauss T., Elisha N., Ravid B. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full-term neonates. Blood Cell Mol Dis. 2017;67:14-7. https://doi.org/10.1016/j.bcmd.2016.12.013.

27. van Ommen C.H., Sol J.J. Developmental hemostasis and management of central venous catheter thrombosis in neonates. Semin Thromb Hemost. 2016;42(7):752-9. https://doi.org/10.1055/s-0036-1592299.

28. Sirachainan N., Limrungsikul A., Chuansumrit A. et al. Incidences, risk factors and outcomes of neonatal thromboembolism. J Matern Fetal Neonatal Med. 2018;31(3):347-51. https://doi.org/10.1080/14767058.2017.1285892.

29. Marquez A., Shabanova V., Faustino E.V.S.; Northeast Pediatric Critical Care Research Consortium. Prediction of catheter-associated thrombosis in critically ill children. Pediatr Crit Care Med. 2016;17(11):e521-e528. https://doi.org/10.1097/PCC.0000000000000958.

30. Rupp M.E., Karnatak R. Intravascular catheter-related bloodstream infections. Infect Dis Clin North Am. 2018;32(4):765-87. https://doi.org/10.1016/j.idc.2018.06.002.

31. Thornburg C.D., Smith P.B., Smithwick M.L. et al. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res. 2008;122(6):782-5. https://doi.org/10.1016/j.thromres.2007.10.001.

32. Amankwah E.K., Atchison C.M., Arlikar S. et al. Risk factors for hospital-associated venous thromboembolism in the neonatal intensive care unit. Thromb Res. 2014;134(2):305-9. https://doi.org/10.1016/j.thromres.2014.05.036.

33. Andres O., Schulze H., Speer C.P. Platelets in neonates: central mediators in haemostasis, antimicrobial defence and inflammation. Thromb Haemost. 2015;113(1):3-12. https://doi.org/10.1160/TH14-05-0476.

34. Vorobev A., Makatsariya A., Bitsadze V. et al. Unusual thrombosis or pregnancy complications associated to ovarian cancers: two clinical cases. J Matern Fetal Neonatal Med. 2021;34(9):1430-4. https://doi.org/10.1080/14767058.2019.1638359.

35. Bhat R., Kumar R., Kwon S. et al. Risk factors for neonatal venous and arterial thromboembolism in the neonatal intensive care unit - a case control study. J Pediatr. 2018;195:28-32. https://doi.org/10.1016/j.jpeds.2017.12.015.

36. Kulkarni A.A., Osmond M., Bapir M. et al. The effect of labour on the coagulation system in the term neonate. Haemophilia. 2013;19(4):533-8. https://doi.org/10.1111/hae.12115.

37. Tuckuviene R., Christensen A.L., Helgested J. et al. Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F417-22. https://doi.org/10.1136/archdischild-2011-300665.

38. Branchford B.R., Mourani P., Bajaj L et al. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012;97(4):509-15. https://doi.org/10.3324/haematol.2011.054775.

39. Motta M., Rodriguez-Perez C., Tincani A. et al. Neonates born from mothers with autoimmune disorders. Early Hum Dev. 2009;85(10 Suppl):S67-70. https://doi.org/10.1016/j.earlhumdev.2009.08.020.

40. van Ommen C.H., Nowak-Gottl U. Inherited thrombophilia in pediatric venous thromboembolic disease: why and who to test. Front Pediatr. 2017;5:50. https://doi.org/10.3389/fped.2017.00050.

41. Sharathkumar A.A., Mahajerin A., Heidt L. et al. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. J Thromb Haemost. 2012;10(7):1326-34. https://doi.org/10.1111/j.1538-7836.2012.04779.x.

42. Ovesen P.G., Jensen D.M., Damm P. et al. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes: a nationwide study. J Matern Fetal Neonatal Med. 2015;28(14):1720-4. https://doi.org/10.3109/14767058.2014.966677.

43. Makatsariya A., Bitsadze V., Khizroeva J. et al. Neonatal thrombosis. J Matern Fetal Neonatal Med. 2020 Mar 23:1-9. https://doi.org/10.1080/14767058.2020.1743668. [Online ahead of print].

44. Kristensen S.R., Kaehne M., Petersen N.E. Hemizygous antithrombindeficiency (Budapest III) in a newborn presenting with a thrombosis at birth. Br J Haematol. 2007;138(3):397-8. https://doi.org/10.1111/j.1365-2141.2007.06662.x.

45. Monagle P., Chan A.K., Goldenberg N.A. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(Suppl 2):e737S-801S. https://doi.org/10.1378/chest.11-2308.

46. Limperger V., Klostermeier U.C., Kenet G. et al. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol. 2014;167(3):385-93. https://doi.org/10.1111/bjh.13039.

47. Lee M.J., Kim K.M., Kim J.S. et al. Long-term survival of a child with homozygous protein C deficiency successfully treated with living donor liver transplantation. Pediatr Transplant. 2009;13(2):251-4. https://doi.org/10.1111/j.1399-3046.2008.00972.x.

48. Klostermeier U.C., Limperger V., Kenet G. et al. Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Thromb Haemost. 2015;113(2):426-33. https://doi.org/10.1160/TH14-06-0533.

49. Zharkov P.A. Influence of polymorphisms carriage of genes of the blood coagulation and folate metabolism on the risk for development of thromboses in adults and children. [Vliyanie nositel'stva polimorfizmov genov svertyvayushchej sistemy krovi i folatnogo obmena na risk razvitiya trombozov u vzroslyh i detej]. Voprosy prakticheskoj pediatrii. 2012;7(5):26-32. (In Russ.).

50. Arnaez J., Arca G., Martin-Ancel A., Garcia-Alix A. Coagulation factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T gene mutations do not play a major role in symptomatic neonatal arterial ischaemic stroke. Br J Haematol. 2018;180(2):290-2. https://doi.org/10.1111/bjh.14308.

51. Kenet G., Lutkhoff L.K., Albisetti M. et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121(16):1838-47. https://doi.org/10.1161/CIRCULATIONAHA.109.913673.

52. Laugesaar R., Kahre T., Kolk A. et al. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a casecontrol study and two meta-analyses. Acta Paediatr. 2010;99(8):1168-74. https://doi.org/10.1111/j.1651-2227.2010.01784.x.

53. Turebylu R., Salis R., Erbe R. et al. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol. 2007;27(8):490-5. https://doi.org/10.1038/sj.jp.7211786.

54. Neshat-Vahid S., Pierce R., Hersey D. et al. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(9):1749-58. https://doi.org/10.1111/jth.13388.

55. Mekinian A., Lachassinne E., Nicaise-Roland P. et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013;72(2):217-22. https://doi.org10.1136/annrheumdis-2011-201167

56. Berkun Y., Simchen M.J., Strauss T. et al. Antiphospholipid antibodies in neonates with stroke - a unique entity or variant of antiphospholipid syndrome? Lupus. 2014;23(10):986-93. https://doi.org/10.1177/0961203314531842.

57. Gordon O., Almagor Y., Fridler D. et al. De novo neonatal antiphospholipid syndrome: a case report and review of the literature. Semin Arthritis Rheum. 2014;44(2):241-5. https://doi.org/10.1016/j.semarthrit.2014.04.003.

58. Fujimura Y., Matsumoto M., Kokame K. et al. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol. 2009;144(5):742-54. https://doi.org/10.1111/j.1365-2141.2008.07515.x.

59. Strauss T., Elisha N., Ravid B. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2017;67:14-7. https://doi.org/10.1016/j.bcmd.2016.12.013.

60. Katneni U.K., Ibla J.C., Hunt R. et al. von Willebrand factor/ADAMTS-13 interactions at birth: implications for thrombosis in the neonatal period. J Thromb Haemost. 2019;17(3):429-40. https://doi.org/10.1111/jth.14374.

61. O'Brien S.H., Kulkarni R., Wallace A. et al. Multicenter dose-finding and efficacy and safety outcomes in neonates and children treated with dalteparin for acute venous thromboembolism. J Thromb Haemost. 2014;12(11):1822-5. https://doi.org/10.1111/jth.12716.

62. van Ommen C.H., van den Dool E.J., Peters M. Nadroparin therapy in pediatric patients with venous thromboembolic disease. J Pediatr Hematol Oncol. 2008;30(3):230-4. https://doi.org/10.1097/MPH.0b013e31816356f8.

63. Malowany J.I., Knoppert D.C., Chan A.K. et al. Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Pharmacotherapy. 2007;27(9):1263-71. https://doi.org/10.1592/phco.27.9.1263.

64. Bauman M.E., Belletrutti M.J., Bajzar L.et al. Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeuticlevels. Thromb Haemost. 2009;101(1):86-92.

65. Klaassen I.L.M., Sol J.J., Suijker M.H. et al. Are low-molecular-weight heparins safe and effective in children? A systematic review. Blood Rev. 2019;33:33-42. https://doi.org/10.1016/j.blre.2018.06.003.

66. Witmer C., Raffini L. Treatment of venous thromboembolism in pediatric patients. Blood. 2020;135(5):335-43. https://doi.org/10.1182/blood.2019001847.

67. Romantsik O., Bruschettini M., Zappettini S. et al. Heparin for the treatment of thrombosis in neonates. Cochrane Database Syst Rev. 2016;11(11):CD012185. https://doi.org/10.1002/14651858.CD012185.pub2.

68. Monagle P., Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program. 2018;2018(1):399-404. https://doi.org/10.1182/asheducation-2018.1.399.